News US regulator grants $23 million to rare disease R&D FDA announces 21 rare disease clinical trial research grants.
News EU regulator recommends Intercept's potential liver blockbus... Sales forecast to reach $2.6 billion in 2020.
News Alnylam plunges after deaths in rare disease trial Biotech axes revusiran due to safety concerns.
News Faron moves ahead with "shock lung" drug Finnish firm eyes first drug for acute respiratory distress syndrome.
News US and EU regulators collaborate on rare diseases Clinical trial design among areas regulators will collaborate on
News Zafgen ends development of Prader-Willi drug Share price plummets after biotech said drug is unsafe.
News GSK to quit Stevenage for new R&D site in Cambridge In a major shake-up of its UK operations, GSK is building a brand new R&D centre in Cambridge and transfer operations there from its Stevenage campus.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
